We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+8.81%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$122M
AUM Growth
-$81.7M
Cap. Flow
-$42.7M
Cap. Flow %
-34.99%
Top 10 Hldgs %
46.72%
Holding
148
New
36
Increased
27
Reduced
31
Closed
34

Top Buys

Rank Stock Value
1
RCL icon
Royal Caribbean
RCL
+$2.8M
2
AVYA
Avaya Holdings Corp. Common Stock
AVYA
+$2.38M
3
AAOI icon
Applied Optoelectronics
AAOI
+$1.6M
4
QUOT
Quotient Technology Inc
QUOT
+$1.11M
5
IPWR icon
Ideal Power
IPWR
+$1.01M

Top Sells

Rank Stock Value
1
COHR icon
Coherent
COHR
+$2.41M
2
SNCR
Synchronoss Technologies
SNCR
+$1.66M
3
APPS icon
Digital Turbine
APPS
+$1.54M
4
FLXN
Flexion Therapeutics, Inc.
FLXN
+$1.34M
5
CLFD icon
Clearfield
CLFD
+$1.01M

Sector Composition

Rank Sector Weight
1 Technology 21.03%
2 Healthcare 9.92%
3 Consumer Discretionary 7.96%
4 Real Estate 3.12%
5 Consumer Staples 2.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAG icon
126
STAG Industrial
STAG
$7.2B
– –
-6,825
Closed -$200K
TVTX icon
127
PUT
Travere Therapeutics
TVTX
$5.82B
– –
-42,800
Closed -$12K
VAC icon
128
Marriott Vacations Worldwide
VAC
$3.47B
– –
-6,746
Closed -$612K
WY icon
129
Weyerhaeuser
WY
$18.6B
– –
-13,500
Closed -$303K
XLF icon
130
State Street Financial Select Sector SPDR ETF
XLF
$58.6B
– –
-11,040
Closed -$255K
XPH icon
131
State Street SPDR S&P Pharmaceuticals ETF
XPH
$505M
– –
-4,673
Closed -$201K
PXD
132
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-6,751
Closed -$659K
ICPT
133
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
– –
-31,300
Closed -$20K
ACOR
134
PUT
DELISTED
Acorda Therapeutics
ACOR
– –
-854
Closed -$66K
FLXN
135
DELISTED
Flexion Therapeutics, Inc.
FLXN
– –
-102,000
Closed -$1.34M
CFRX
136
DELISTED
ContraFect Corporation
CFRX
– –
-438
Closed -$224K
ABK
137
CALL
DELISTED
Ambac Financial Group
ABK
– –
-41,400
Closed -$123K
BDSI
138
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-143,676
Closed -$626K
2 3 4 5
6

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Worth Venture Partners held 148 positions worth $122M, down 40% from $204M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Worth Venture Partners withdrew a net $42.7M in Q3 2020, closing 34 positions and reducing 31 holdings. Its most notable exit was Coherent, an estimated $2.41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Worth Venture Partners opened a new position in Royal Caribbean worth $3.08M.

  • Worth Venture Partners's largest Q3 2020 buy was Royal Caribbean: 47,526 shares worth $3.08M.
  • Worth Venture Partners added most to Ideal Power in Q3 2020, an estimated $1.01M increase.
  • Worth Venture Partners's biggest Q3 2020 reduction was Digital Turbine, cutting an estimated $1.54M.
  • Worth Venture Partners fully exited Coherent in Q3 2020, selling an estimated $2.41M.
  • Worth Venture Partners's ten largest holdings make up 47% of its $122M portfolio in Q3 2020.
  • Worth Venture Partners opened 36 new positions and closed 34 in Q3 2020.
  • Worth Venture Partners's portfolio value fell 40% quarter-over-quarter to $122M.

Based on Worth Venture Partners's 13F filing for Q3 2020, filed 16 Nov 2020.